Actavis' superbug antibiotic gets U.S. approval

Reuters: The U.S Food and Drug Administration approved on Wednesday Actavis Plc's antibiotic to treat two infections caused by drug-resistant bacteria, or superbugs.

The decision comes after a panel advising the agency recommended approval of the drug, Avycaz, in December.

Read article